37.24
price down icon3.24%   -1.03
 
loading

Grail Inc Borsa (GRAL) Ultime notizie

pulisher
Jul 28, 2025

How strong is GRAIL LLC company’s balance sheetRetirement Planning Insights With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What markets is GRAIL LLC expanding into Is Cadiz Inc. stock a good long term investment optionDiscover high-impact stocks for your portfolio - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying GRAIL LLC stockRapid portfolio appreciation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes GRAIL LLC stock price move sharplyAchieve consistent double-digit growth rates - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What analysts say about GRAIL LLC stock outlookCapital Preservation Investment Ideas - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

Is GRAIL LLC a good long term investmentExplosive earning power - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about GRAIL LLC stockFree Stock Market Real-Time Monitoring - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

"The Grail Collection" Could Be a Game-Changer for MDCE (OTC:MDCE)Jordan, Curry, and NBA Royalty Up for Bid - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem - GlobeNewswire Inc.

Jul 25, 2025
pulisher
Jul 24, 2025

GRAIL LLC Stock Analysis and ForecastBreakout portfolio performance - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives GRAIL LLC stock priceHigh-yield trading alerts - Autocar Professional

Jul 23, 2025
pulisher
Jul 21, 2025

Freenome's new CEO is ready to compete in race for tests that can detect cancer earlySan Francisco Business Times - The Business Journals

Jul 21, 2025
pulisher
Jul 21, 2025

(GRAL) Technical Data - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 18, 2025

Grail posts latest trial data for Galleri cancer detection test - MSN

Jul 18, 2025
pulisher
Jul 17, 2025

Grail’s CFO Freidin sells $311k in common stock By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Grail’s CFO Freidin sells $311k in common stock - Investing.com Australia

Jul 17, 2025
pulisher
Jul 16, 2025

Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid ‘Equal Weight’ Stance - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

GRAIL’s Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission - MSN

Jul 15, 2025
pulisher
Jul 13, 2025

12 Best Young Stocks To Buy and Hold For 5 Years - Insider Monkey

Jul 13, 2025
pulisher
Jul 12, 2025

Illumina: A Compelling Buy Despite GRAIL Divestiture and Macroeconomic Challenges - AInvest

Jul 12, 2025
pulisher
Jul 12, 2025

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds - Seeking Alpha

Jul 12, 2025
pulisher
Jul 09, 2025

Grail (GRAL): A High-Reward, High-Risk Play on Cancer Detection's Future - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

15 Successful Spin-Off Companies and Their 2025 Returns - Insider Monkey

Jul 09, 2025
pulisher
Jul 08, 2025

GRAIL Insiders Selling US$10m In Stock Relieved As Market Cap Slides To US$1.7b - simplywall.st

Jul 08, 2025
pulisher
Jul 01, 2025

GRAIL's Insider Sales: Red Flag or Strategic Move? Assessing Executive Confidence Amid Strong Financials - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

(GRAL) Trading Report - news.stocktradersdaily.com

Jun 30, 2025
pulisher
Jun 29, 2025

GRAIL, Inc.(NasdaqGS: GRAL) dropped from Russell Midcap Index - MarketScreener

Jun 29, 2025
pulisher
Jun 26, 2025

Galleri Early Detection Test May Improve Cancer Detection vs SOC Alone - CancerNetwork

Jun 26, 2025
pulisher
Jun 25, 2025

Morgan Stanley raises Grail stock price target to $38 on cancer test potential - Investing.com

Jun 25, 2025
pulisher
Jun 20, 2025

Grail plans FDA filing for cancer blood test after new trial - pharmaphorum

Jun 20, 2025
pulisher
Jun 19, 2025

Grail reports positive outcomes from registrational study of Galleri test - Yahoo Home

Jun 19, 2025
pulisher
Jun 19, 2025

PATHFINDER 2 Trial Releases Positive Topline Data for Multicancer Early Detection Test - OncLive

Jun 19, 2025
pulisher
Jun 18, 2025

Grail plans to submit updated Galleri blood test for FDA approval next year - Fierce Biotech

Jun 18, 2025
pulisher
Jun 18, 2025

Grail stock gains on new data for Galleri cancer test (GRAL) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

GRAIL reports positive results from cancer detection test study By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

GRAIL reports positive results from cancer detection test study - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Grail reports results from PATHFINDER 2 study - TipRanks

Jun 18, 2025
diagnostics_research WAT
$301.83
price down icon 0.22%
$135.79
price down icon 1.33%
diagnostics_research DGX
$168.15
price up icon 0.43%
diagnostics_research LH
$261.20
price down icon 0.18%
diagnostics_research MTD
$1,256.31
price down icon 0.09%
diagnostics_research IQV
$196.60
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):